Synthesis of novel 3-halo-3-nitroflavanones and their activities as DNA methyltransferase inhibitors in cancer cells
Authors:
- 1 January 2020
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 186, 111829
Abstract
No abstract availableKeywords
Funding Information
- Les Laboratories Pierre Fabre
- Centre National de la Recherche Scientifique
- Institut National Du Cancer (EPIG201401)
- Institut National Du Cancer (N?EPIG201401)
This publication has 18 references indexed in Scilit:
- Development of a universal radioactive DNA methyltransferase inhibition test for high-throughput screening and mechanistic studiesNucleic Acids Research, 2013
- DNA methylation: roles in mammalian developmentNature Reviews Genetics, 2013
- Facile and Highly Stereoselective One-Pot Synthesis of Either (E)- or (Z)-Nitro AlkenesOrganic Letters, 2008
- DNA methylation and gene silencing in cancerNature Clinical Practice Oncology, 2005
- Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2′-deoxycytidine (decitabine) in hematopoietic malignanciesBlood, 2004
- Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpA sitesJournal of Molecular Biology, 2001
- Epigenetic effects in eukaryotic gene expressionDevelopmental Genetics, 1994
- Synthesis of 2-Aryl-3-nitro-4H-1-benzopyran-4-onesSynthesis, 1992
- A Convenient Synthesis of 3-Chloro-3,4-dihydro-4-hydroxy-3-nitro-2-phenyl-2H-1-benzopyransSynthesis, 1990
- A One-Step Synthesis of 3-Nitroflavanones and their Conversion to 3-NitroflavonesSynthesis, 1981